{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2023"],"condition":["Neoplasm Metastasis","Liver Neoplasms","For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method"],"disease":["Neoplasm Metastasis","Liver Neoplasms","For Patients With Colorectal Cancer Liver Metastases Who Were Not Able To Curative Surgical Resection.focused On The Treatment Effect With The Quintuple Method"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/11945"],"location":["China"],"study_start_month":["3"],"keyword":["Folic Acid","Vitamin A","Oxaliplatin","Tegafur","Metronidazole","Cetuximab","Colorectal Liver Metastases","Quintuple method"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases","description":"The aim of this study is to explore the therapeutic effect of Quintuple method in the treatment of patients with multiple and refractory liver metastases from colorectal cancer. A randomized single-arm clinical trial was conducted.The intervention group was treated with single SOX chemotherapy, SOX chemotherapy combined with cetuximab targeted therapy, SOX chemotherapy combined with low-dose cetuximab targeted therapy combined with three-drug regimen（Quintuple method）, and the RECIST 1.1 solid tumor evaluation criteria were used to assess the disease.","dates":{"creation":"2023-03-15"},"accession":"11945","cross_references":{"ClinicalTrials___gov":["NCT05774964"]}}